Given the important role trust plays in shared decision-making, clinicians working with MM patients should prioritize establishing positive, trusting...
The magnitude of OS benefit with upfront HDT is cytogenetics-dependent. Patients with high-risk cytogenetics should preferably receive upfront rather...
This is likely attributable to underlying disease biology and prevention of end-organ damage by early treatment initiation, as benefit was independent...